Stay updated on Gilead Sciences Press Releases

Sign up to get notified when there's something new on the Gilead Sciences Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Gilead Sciences Press Releases page

  1. Check
    4 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    The Newsroom listing now includes two new items: an August 27, 2026 FDA approval for Bixlenvo and an August 26, 2026 notice about upcoming investor conferences; older June 2026 Trodelvy-related press releases have been removed from the listing.
    Difference
    4%
    Check dated 2026-08-31T16:16:45.000Z thumbnail image
  3. Check
    18 days ago
    Change Detected
    Summary
    A new August 24, 2026 News Release on Trodelvy in first-line metastatic triple-negative breast cancer was added to the News Releases list, and the June 15, 2026 U.S. FDA acceptance of an investigational HIV prevention treatment was removed from the list.
    Difference
    4%
    Check dated 2026-08-24T17:08:03.000Z thumbnail image
  4. Check
    25 days ago
    No Change Detected
  5. Check
    32 days ago
    Change Detected
    Summary
    Added a Newsroom entry for August 4, 2026 announcing Gilead Sciences' Second Quarter 2026 Financial Results. Removed the June 12, 2026 entry about rapid Remdesivir donation for Ebola relief from the Newsroom.
    Difference
    4%
    Check dated 2026-08-10T10:48:48.000Z thumbnail image
  6. Check
    40 days ago
    Change Detected
    Summary
    No changes are present in the provided data for the News page. The page content snapshot remains unchanged.
    Difference
    0.5%
    Check dated 2026-08-03T06:30:12.000Z thumbnail image
  7. Check
    47 days ago
    Change Detected
    Summary
    Several July 2026 News Releases headlines were added (including CHMP Recommends Gilead’s Trodelvy® Plus Keytruda® in PD-(L)1-Positive First-Line Metastatic Triple-Negative Breast Cancer and the Gilead Sciences to Release Second Quarter 2026 Financial Results on Tuesday, August 4, 2026). At the same time, older June 2026 items were removed from the list, updating the feed to reflect current and past news in the timeline.
    Difference
    4%
    Check dated 2026-07-27T06:29:50.000Z thumbnail image
  8. Check
    76 days ago
    Change Detected
    Summary
    Adds two new News Releases announcing Trodelvy approvals in the U.S. and Europe, and removes two older items (Ouro Medicines acquisition and Seladelpar PBC trial results) from the News Releases list.
    Difference
    4%
    Check dated 2026-06-28T08:39:40.000Z thumbnail image

Stay in the know with updates to Gilead Sciences Press Releases

Enter your email address, and we'll notify you when there's something new on the Gilead Sciences Press Releases page.